Hematological cancer in 2011: New therapeutic targets and treatment strategies.
about
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Investigative and clinical applications of synthetic immune synapsesMechanisms of epigenetic regulation of leukemia onset and progressionFailure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinicPerifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.Pain Phenotypes and Associated Clinical Risk Factors Following Traumatic Amputation: Results from Veterans Integrated Pain Evaluation Research (VIPER).Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences.
P2860
Q26783433-42DAA5F5-F91E-47B5-BFD2-282E6C4ADF4BQ26825315-32982220-3CA7-43A1-8226-863D462BD331Q26861785-DB908581-6BDD-4859-8C43-38A793EC50E0Q34786452-2D9B773A-5C13-4095-A0B4-3556CE270036Q36187369-5ADABB44-401F-4AB0-A01B-3E7B76BA49D9Q39101546-70E28E83-B828-4783-8639-13A7FB48E669Q39202496-7BAAD3F9-944B-4EF2-B4F7-B18D70B82163Q45328060-96CC981C-E86A-45A7-8C34-24E79DEB22BBQ48077006-E3B9A023-8021-405F-B1F3-2A745DC19AEE
P2860
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
@en
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
@nl
type
label
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
@en
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
@nl
prefLabel
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
@en
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
@nl
P2860
P1476
Hematological cancer in 2011: New therapeutic targets and treatment strategies.
@en
P2093
Paula Cramer
P2860
P2888
P356
10.1038/NRCLINONC.2011.212
P407
P577
2012-01-10T00:00:00Z
P6179
1019897168